Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinlin Liu

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Biological Macromolecules|December 4, 2025
Antibody-based targeted protein degradation: Mechanisms, challenges and future directionsYujing Li, Wanpeng Yu, Xiyao Wang, et al.
Protein Expression and Purification|March 8, 2017
Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coliDaning Wang, Fei Fan, Zhihai Li, et al.
Scientific Reports|January 12, 2016
A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5Lin Xia, Yangfei Xian, Daning Wang, et al.
Pharmacology & Therapeutics|December 11, 2023
Clinical advances in TNC delivery vectors and their conjugate agentsWujun Chen, Yudong Wu, Jie Wang, et al.
Journal of Nanobiotechnology|September 15, 2022
A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding modeDongping Zhao, Liqin Liu, Xinlin Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2026
Materials-Guided Gene-Ionizable Lipid Nanoparticles to Reverse Iron-Associated Immune Resistance in Renal CancerXin Jin, Yulong Hong, Chengliang Yin, et al.
Emerging Microbes & Infections|November 27, 2019
Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infectionXinlin Liu, Jie Chen, Zhiping Wang, et al.
Mbio|September 28, 2017
Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human PapillomavirusZhihai Li, Daning Wang, Ying Gu, et al.
Nature Communications|December 19, 2018
Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificityZhihai Li, Shuo Song, Maozhou He, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2019
Viral neutralization by antibody-imposed physical disruptionQingbing Zheng, Jie Jiang, Maozhou He, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Biological Macromolecules|December 4, 2025
Antibody-based targeted protein degradation: Mechanisms, challenges and future directionsYujing Li, Wanpeng Yu, Xiyao Wang, et al.
Protein Expression and Purification|March 8, 2017
Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coliDaning Wang, Fei Fan, Zhihai Li, et al.
Scientific Reports|January 12, 2016
A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5Lin Xia, Yangfei Xian, Daning Wang, et al.
Pharmacology & Therapeutics|December 11, 2023
Clinical advances in TNC delivery vectors and their conjugate agentsWujun Chen, Yudong Wu, Jie Wang, et al.
Journal of Nanobiotechnology|September 15, 2022
A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding modeDongping Zhao, Liqin Liu, Xinlin Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2026
Materials-Guided Gene-Ionizable Lipid Nanoparticles to Reverse Iron-Associated Immune Resistance in Renal CancerXin Jin, Yulong Hong, Chengliang Yin, et al.
Emerging Microbes & Infections|November 27, 2019
Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infectionXinlin Liu, Jie Chen, Zhiping Wang, et al.
Mbio|September 28, 2017
Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human PapillomavirusZhihai Li, Daning Wang, Ying Gu, et al.
Nature Communications|December 19, 2018
Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificityZhihai Li, Shuo Song, Maozhou He, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2019
Viral neutralization by antibody-imposed physical disruptionQingbing Zheng, Jie Jiang, Maozhou He, et al.
Pageof 9